Mitf regulation of Dia1 controls melanoma proliferation and invasiveness

被引:479
作者
Carreira, Suzanne
Goodall, Jane
Denat, Laurence
Rodriguez, Mercedes
Nuciforo, Paolo
Hoek, Keith S.
Testori, Alessandro
Larue, Lionel
Goding, Colin R. [1 ]
机构
[1] Marie Curie Res Inst, Signalling & Dev Lab, Oxted RH8 0TL, Surrey, England
[2] Inst Curie, CNRS, UMR146, F-91405 Orsay, France
[3] FIRC, Inst Mol Oncol, I-20139 Milan, Italy
[4] Ist Europeo Oncol, Melanoma Unit, I-20141 Milan, Italy
关键词
Dia1; melanoma; Mitf; actin; p27;
D O I
10.1101/gad.406406
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
It is widely held that cells with metastatic properties such as invasiveness and expression of matrix metalloproteinases arise through the stepwise accumulation of genetic lesions arising from genetic instability and "clonal evolution." By contrast, we show here that in melanomas invasiveness can be regulated epigenetically by the microphthalmia-associated transcription factor, Mitf, via regulation of the DIAPH1 gene encoding the diaphanous-related formin Dia1 that promotes actin polymerization and coordinates the actin cytoskeleton and microtubule networks at the cell periphery. Low Mitf levels lead to down-regulation of Dia1, reorganization of the actin cytoskeleton, and increased ROCK-dependent invasiveness, whereas increased Mitf expression leads to decreased invasiveness. Significantly the regulation of Dia1 by Mitf also controls p27(Kip1)-degradation such that reduced Mitf levels lead to a p27(Kip1)-dependent G1 arrest. Thus Mitf, via regulation of Dia1, can both inhibit invasiveness and promote proliferation. The results imply variations in the repertoire of environmental cues that determine Mitf activity will dictate the differentiation, proliferative, and invasive/migratory potential of melanoma cells through a dynamic epigenetic mechanism.
引用
收藏
页码:3426 / 3439
页数:14
相关论文
共 60 条
[1]
Diaphanous-related Formin homology proteins [J].
Alberts, AS .
CURRENT BIOLOGY, 2002, 12 (23) :R796-R796
[2]
Progression in cutaneous malignant melanoma is associated with distinct expression profiles -: A tissue microarray-based study [J].
Alonso, SR ;
Ortiz, P ;
Pollán, M ;
Pérez-Gómez, B ;
Sánchez, L ;
Acuña, MJ ;
Pajares, R ;
Martínez-Tello, FJ ;
Hortelano, CM ;
Piris, MA ;
Rodríguez-Peralto, JL .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) :193-203
[3]
Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase [J].
Arber, S ;
Barbayannis, FA ;
Hanser, H ;
Schneider, C ;
Stanyon, CA ;
Bernard, O ;
Caroni, P .
NATURE, 1998, 393 (6687) :805-809
[4]
High levels of expression of p27KIP1 and cyclin E in invasive primary malignant melanomas [J].
Bales, ES ;
Dietrich, C ;
Bandyopadhyay, D ;
Schwahn, DJ ;
Xu, WD ;
Didenko, V ;
Leiss, P ;
Conrad, N ;
Pereira-Smith, O ;
Orengo, I ;
Medrano, EE .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (06) :1039-1046
[5]
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? [J].
Baylin, SB ;
Ohm, JE .
NATURE REVIEWS CANCER, 2006, 6 (02) :107-116
[6]
Metastasis genes: A progression puzzle [J].
Bernards, R ;
Weinberg, RA .
NATURE, 2002, 418 (6900) :823-823
[7]
MITF and cell proliferation: the role of alternative splice forms [J].
Bismuth, K ;
Maric, D ;
Arnheiter, H .
PIGMENT CELL RESEARCH, 2005, 18 (05) :349-359
[8]
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 [J].
Carrano, AC ;
Eytan, E ;
Hershko, A ;
Pagano, M .
NATURE CELL BIOLOGY, 1999, 1 (04) :193-199
[9]
Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression [J].
Carreira, S ;
Goodall, J ;
Aksan, I ;
La Rocca, SA ;
Galibert, MD ;
Denat, L ;
Larue, L ;
Goding, CR .
NATURE, 2005, 433 (7027) :764-769
[10]
The gene encoding the T-box factor Tbx2 is a target for the microphthalmia-associated transcription factor in melanocytes [J].
Carreira, S ;
Liu, BG ;
Goding, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (29) :21920-21927